Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

A randomized controlled trial on the effect of vitamin D3 on inflammation and cathelicidin gene expression in ulcerative colitis patients.

Sharifi A, Hosseinzadeh-Attar MJ, Vahedi H, Nedjat S.

Saudi J Gastroenterol. 2016 Jul-Aug;22(4):316-23. doi: 10.4103/1319-3767.187606.

2.

Oral pathology in inflammatory bowel disease.

Muhvić-Urek M, Tomac-Stojmenović M, Mijandrušić-Sinčić B.

World J Gastroenterol. 2016 Jul 7;22(25):5655-67. doi: 10.3748/wjg.v22.i25.5655. Review.

3.

Importance of the Evaluation of N-Acetyltransferase Enzyme Activity Prior to 5-Aminosalicylic Acid Medication for Ulcerative Colitis.

Matthis AL, Zhang B, Denson LA, Yacyshyn BR, Aihara E, Montrose MH.

Inflamm Bowel Dis. 2016 Aug;22(8):1793-802. doi: 10.1097/MIB.0000000000000823.

PMID:
27416043
4.

Liquid chromatography-mass spectrometry for measuring deoxythioguanosine in DNA from thiopurine-treated patients.

Coulthard SA, Berry P, McGarrity S, Ansari A, Redfern CP.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Aug 15;1028:175-80. doi: 10.1016/j.jchromb.2016.06.017. Epub 2016 Jun 15.

5.

Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review.

Nidhi, Rashid M, Kaur V, Hallan SS, Sharma S, Mishra N.

Saudi Pharm J. 2016 Jul;24(4):458-72. doi: 10.1016/j.jsps.2014.10.001. Epub 2014 Oct 22. Review.

6.

DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing.

Issa NT, Kruger J, Wathieu H, Raja R, Byers SW, Dakshanamurthy S.

BMC Bioinformatics. 2016 May 5;17(1):202. doi: 10.1186/s12859-016-1065-y.

7.

Anti-inflammatory effects of novel AP-1 and NF-κB inhibitors in dextran-sulfate-sodium-induced colitis in rats.

El-Salhy M, Umezawa K.

Int J Mol Med. 2016 Jun;37(6):1457-64. doi: 10.3892/ijmm.2016.2560. Epub 2016 Apr 12.

8.

Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn's Disease: Results from the CONNECT Study.

Kwon JH, Im JP, Ye BD, Cheon JH, Jang HJ, Lee KM, Kim YS, Kim SW, Kim YH, Song GA, Han DS, Kim WH, Kim JS.

Gut Liver. 2016 Jul 15;10(4):595-603. doi: 10.5009/gnl15411.

9.

Noninvasive evaluation of active pan-ulcerative colitis with multiple strictures using Fluorine-18-Fluorodeoxyglucose positron emission tomography/computed tomography.

Santhosh S, Bhattacharya A, Rana SS, Bhasin DK, Gupta R, Mittal BR.

Indian J Nucl Med. 2016 Jan-Mar;31(1):65-6. doi: 10.4103/0972-3919.172367.

10.

Efficacy and safety of two pH-dependent-release mesalamine doses in moderately active ulcerative colitis: a multicenter, randomized, double-blind, parallel-group study.

Suzuki Y, Iida M, Ito H, Saida I, Hibi T.

Intest Res. 2016 Jan;14(1):50-9. doi: 10.5217/ir.2016.14.1.50. Epub 2016 Jan 26.

11.

Acute pancreatitis as a complication of childhood cancer treatment.

Stefanović M, Jazbec J, Lindgren F, Bulajić M, Löhr M.

Cancer Med. 2016 May;5(5):827-36. doi: 10.1002/cam4.649. Epub 2016 Feb 13. Review.

12.

Advances in nutritional therapy in inflammatory bowel diseases: Review.

Wędrychowicz A, Zając A, Tomasik P.

World J Gastroenterol. 2016 Jan 21;22(3):1045-66. doi: 10.3748/wjg.v22.i3.1045. Review.

13.

Development of Advanced Imaging Criteria for the Endoscopic Identification of Inflammatory Polyps.

Sussman DA, Barkin JA, Martin AM, Varma T, Clarke J, Quintero MA, Barkin HB, Deshpande AR, Barkin JS, Abreu MT.

Clin Transl Gastroenterol. 2015 Nov 19;6:e128. doi: 10.1038/ctg.2015.51.

14.

Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab against Crohn's Disease.

Urabe S, Isomoto H, Ishida T, Maeda K, Inamine T, Kondo S, Higuchi N, Sato K, Uehara R, Yajima H, Machida H, Chen CC, Fukuda Y, Takeshima F, Nakao K, Tsukamoto K.

Biomed Res Int. 2015;2015:416838. doi: 10.1155/2015/416838. Epub 2015 Oct 19.

15.

Diagnostic value of terminal ileum biopsies in patients with abnormal terminal ileum mucosal appearance.

Velidedeoğlu M, Enes Arıkan A, Kağan Zengin A.

Ulus Cerrahi Derg. 2015 Apr 9;31(3):152-6. doi: 10.5152/UCD.2015.2756. eCollection 2015.

16.

Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments.

de Mattos BR, Garcia MP, Nogueira JB, Paiatto LN, Albuquerque CG, Souza CL, Fernandes LG, Tamashiro WM, Simioni PU.

Mediators Inflamm. 2015;2015:493012. doi: 10.1155/2015/493012. Epub 2015 Aug 3. Review.

17.
18.

Efficacy and Safety of Long-Term Thiopurine Maintenance Treatment in Japanese Patients With Ulcerative Colitis.

Yamada S, Yoshino T, Matsuura M, Kimura M, Koshikawa Y, Minami N, Toyonaga T, Honzawa Y, Nakase H.

Intest Res. 2015 Jul;13(3):250-8. doi: 10.5217/ir.2015.13.3.250. Epub 2015 Jun 9.

19.

First-in-Human Case Study: Pregnancy in Women With Crohn's Perianal Fistula Treated With Adipose-Derived Stem Cells: A Safety Study.

Sanz-Baro R, García-Arranz M, Guadalajara H, de la Quintana P, Herreros MD, García-Olmo D.

Stem Cells Transl Med. 2015 Jun;4(6):598-602. doi: 10.5966/sctm.2014-0255. Epub 2015 Apr 29.

20.

The th17/treg immune balance in ulcerative colitis patients with two different chinese syndromes: dampness-heat in large intestine and spleen and kidney yang deficiency syndrome.

Gong Y, Liu L, He X, Zhao H, Yang J, Li L, Lu A, Lin Y, Jiang M.

Evid Based Complement Alternat Med. 2015;2015:264317. doi: 10.1155/2015/264317. Epub 2015 Mar 1.

Items per page

Supplemental Content

Write to the Help Desk